Jain Global’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Buy
216,543
+169,991
+365% +$245K ﹤0.01% 1250
2026
Q1
$59.1K Sell
46,552
-5,497
-11% -$10.3K ﹤0.01% 1139
2025
Q4
$124K Buy
+52,049
New +$142K ﹤0.01% 1088

Other funds holding HCAT

Jain Global's HCAT Position: Q2 2026 in Review

Jain Global increased its Health Catalyst (HCAT) stake by 365% in Q2 2026, buying an estimated $245K and bringing the position to 216,543 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

Jain Global first reported a position in HCAT in Q4 2025 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Jain Global held 216,543 shares of Health Catalyst worth $431K as of Q2 2026.
  • Jain Global bought 169,991 Health Catalyst shares in Q2 2026, an estimated $245K.
  • Health Catalyst made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1250 holding.
  • Jain Global first reported a position in Health Catalyst in Q4 2025 and has held it in 3 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.